Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Single-Blind, Phase Ⅱ Clinical Trial and Open Label Long-term Observation Study of ADSTEM Inj. to Evaluate the Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

NCT04137562 is registered in ClinicalTrials.gov with EHL Bio Co., Ltd. as lead sponsor.

NCT NCT04137562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04137562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Single-Blind, Phase Ⅱ Clinical Trial and Open Label Long-term Observation Study of ADSTEM Inj. to Evaluate the Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis
Lead sponsor
EHL Bio Co., Ltd.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 11, 2019
Completion date
October 31, 2027
Enrollment
118 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis